Australia has the ability to produce mRNA vaccines: Minister

The senior minister of the Morrison government states that Australia has the ability to produce mRNA-type COVID-19 vaccines such as Pfizer and Modana, but it does not currently have the capacity to produce them on a large scale.

The Pfizer vaccine is recommended by Australian health authorities to people under the age of 50 after the domestic treatment of AstraZeneca is associated with blood clotting and disrupts the vaccination program.

The government has secured an additional 20 million Pfizer vaccines, but they will not arrive until the end of the year.

Interior Minister Karen Andrews, who until recently was Minister of Science and Technology, states that it is “absolutely” possible for Australia to produce RNA vaccines.

“Australia has the capacity to produce mRNA vaccines. Currently, it does not have the capacity to produce them on a large scale,” she told Sky News’ Sunday Agenda program.

She said work was already underway to make that happen.

Meanwhile, the national cabinet will meet on Monday to discuss how to deploy the vaccine and open up the future economy and perhaps move to home quarantine.

“All we have to do is look wisely at how we can bring people to Australia so that we can restart the economy,” Andrews said.

“What we shouldn’t do is jump into the solution now, without all the evidence in front of us.”

Meanwhile, authorities will continue to review all vaccines in use after the death of a 48-year-old woman believed to be associated with AstraZeneca COVID-19 Jab.

A safety group convened by the Therapeutic Goods Department concluded that cases of blood clots in women in NSW with low platelet counts were likely related to vaccination on April 8.

Government advice on the use of AstraZeneca jab was changed the same day that Genen Norris was inoculated, prompting Australians under the age of 50 not to take it.

She was hospitalized four days later and died last week.

TGA secretary John Skellit said her case was “atypical” and would undergo further review of her underlying condition and other blood tests and samples.

This case is likely to be the subject of an inquest.

It is the third in Australia with a thrombus with low platelet count after vaccination, and the first two cases are still in the hospital.

To date, Australia has received approximately 885,000 doses of AstraZeneca.

Chief Medical Officer Paul Kelly has confirmed that some Australians have been reluctant to administer the vaccine since the medical advice on AstraZeneca jab was updated.

However, a study from Oxford University found that the risk of blood clots in the brain after COVID-19 infection was eight times higher than that of AstraZeneca jab, stressing that the vaccine is safer than the alternative.

Meanwhile, COVID-19 appears to have jumped between adjacent rooms in the Sydney Hotel Quarantine after it was revealed on Saturday that seven cases from two family groups had the same virus sequence.

You may need to reclassify it as locally acquired.

Colin Brinsden